Publications
2021
- Impact de la première dose de vaccin contre la COVID-19 dans les CHSLD et les RPA
- Proposition de mesures à déployer dans les écoles primaires et secondaires afin de réduire la transmission de la COVID-19 et assurer une scolarisation en présentiel pour l’année 2021-2022
- SARS-CoV-2 transmission: Findings and proposed terminology
- Transmission du SRAS-CoV-2 : constats et proposition de terminologie
2020
- Vaccination contre l’hépatite A des enfants nés d’avril 2013 à mai 2019
- Les activités de vaccination en période de pandémie de COVID-2019 - Version 2.0 du 6 mai 2020
- Mesures à mettre en place pour les hôtels qui accueilleront des personnes en isolement volontaire ou obligatoire (asymptomatiques) ou des personnes atteintes de COVID-19 ou sous investigation qui ne peuvent être isolées à la maison
2019
- Évaluation du webinaire sur la vaccination contre les virus du papillome humain (VPH) pour les infirmières scolaires - 2018
- Évaluation du webinaire sur la vaccination contre les virus du papillome humain (VPH) pour les infirmières scolaires – 2017
- Groupes supplémentaires qui pourraient être visés par une vaccination gratuite contre les virus du papillome humain (VPH)
- Portrait de l’incidence et de la mortalité des cancers associés aux virus du papillome humain (VPH) : mise à jour de l’incidence 2008-2010 et de la mortalité 2008-2012
Publications
2023
- School-based vaccination program against HPV and Hepatitis B: A longitudinal analysis of vaccine coverage between 2015 and 2021 in Quebec
- Self-reported Human Papillomavirus Vaccination and Vaccine Effectiveness Among Men Who Have Sex with Men: A Quantitative Bias Analysis
- Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
- BNT162b2 effectiveness against Delta and Omicron variants of SARS-CoV-2 in adolescents aged 12-17 years, by dosing interval and duration
- Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men
2022
- Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada
- Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
- Increases in human papillomavirus vaccine coverage over 12 months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada
- Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study
- Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic
- Impact of the first vaccine dose on COVID-19 and its complications in long-term care facilities and private residences for seniors in Québec, Canada
- Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada
2021
- Human papillomavirus (HPV) vaccination across a cascade of knowledge, willingness, and uptake among gay, bisexual, and other men who have sex with men in Canada's three largest cities
- Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women